Learn about the latest advancements in immunotherapy research focusing on harnessing IL-12 for the treatment of ovarian cancer to potentially improve survival rates.

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Investigators evaluated the effectiveness of an immunotherapy in combination with standard radiation therapy for patients with intermediate-high risk localized prostate cancer.

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

The trial is spearheaded by Dr Jonathan Hernandez, the surgical oncology section chief of the National Cancer Institute.

Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...

Werewolf Therapeutics, Inc. (the 'Company” or 'Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...

ImmunityBio, Inc. (NASDAQ: IBRX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for ANKTIVA® (nogapendekin alfa ...

Three Democratic-led states that offered free health care to low-income people who are in the U.S. without legal permission ...

A new immunotherapy trial to treat the deadliest form of brain cancer is seeking patients after one man had remarkable results that saw his tumour vanish. The NHS study will recruit 16 people over an ...